-
Anheuser-Busch Is A Better Company Now Than It Was 12 Months Ago
Monday, October 10, 2016 - 10:35am | 362Goldman Sachs reinstated coverage of Anheuser Busch Inbev SA (ADR) (NYSE: BUD) at Buy, as it believes the shares will likely see a 19 percent upside to its 12-month price target. The firm is of the view that the company appears to be a better business now than it was 12 months ago. 3Q Earnings:...
-
Goldman Reinstates Anheuser-Busch With Buy Rating
Monday, October 10, 2016 - 9:02am | 345Goldman Sachs’ Mitch Collett believes that the acquisition of SABMiller has multiple positive implications for Anheuser Busch Inbev SA (ADR) (NYSE: BUD), including improving its ability to grow, expanding its market share and end-market concentration, and diversifying its revenues. Collett...
-
Drink Up: A Weaker GBP Will Boost The Scotch Business
Tuesday, June 28, 2016 - 9:41am | 285Most British stocks have been in free-fall since the U.K. voted to leave the European Union. last week, but Goldman Sachs analyst Mitch Collett believes some British stocks are much better off than others. Goldman has severely cut its outlook for both U.K. and Eurozone GDP growth due to the...
-
British American Tobacco Upgraded From Sell To Conviction List Buy
Tuesday, June 28, 2016 - 9:21am | 268Although there are expectations of weaker UK and EU GDP growth, there is low correlation between GDP and most European Staples categories, Goldman Sachs’ Mitch Collett said in a report. He upgraded British American Tobacco PLC (ADR) (NYSE: BTI) from Sell to Buy, while adding the stock to...